1040 related articles for article (PubMed ID: 24726434)
1. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.
Suvà ML; Rheinbay E; Gillespie SM; Patel AP; Wakimoto H; Rabkin SD; Riggi N; Chi AS; Cahill DP; Nahed BV; Curry WT; Martuza RL; Rivera MN; Rossetti N; Kasif S; Beik S; Kadri S; Tirosh I; Wortman I; Shalek AK; Rozenblatt-Rosen O; Regev A; Louis DN; Bernstein BE
Cell; 2014 Apr; 157(3):580-94. PubMed ID: 24726434
[TBL] [Abstract][Full Text] [Related]
2. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
[TBL] [Abstract][Full Text] [Related]
3. SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines.
Fiscon G; Conte F; Paci P
BMC Bioinformatics; 2018 Nov; 19(Suppl 15):436. PubMed ID: 30497369
[TBL] [Abstract][Full Text] [Related]
4. Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes.
Yang CM; Chiba T; Brill B; Delis N; von Manstein V; Vafaizadeh V; Oellerich T; Groner B
Int J Cancer; 2015 Nov; 137(10):2296-309. PubMed ID: 25991553
[TBL] [Abstract][Full Text] [Related]
5. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.
Wu Y; Richard JP; Wang SD; Rath P; Laterra J; Xia S
Cancer Sci; 2012 Jun; 103(6):1028-37. PubMed ID: 22380883
[TBL] [Abstract][Full Text] [Related]
6. Computational identification of specific genes for glioblastoma stem-like cells identity.
Fiscon G; Conte F; Licursi V; Nasi S; Paci P
Sci Rep; 2018 May; 8(1):7769. PubMed ID: 29773872
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma-initiating cells.
Dali R; Verginelli F; Pramatarova A; Sladek R; Stifani S
Mol Oncol; 2018 Jun; 12(6):775-787. PubMed ID: 29316219
[TBL] [Abstract][Full Text] [Related]
8. DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2.
Lopez-Bertoni H; Lal B; Li A; Caplan M; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Glas M; Scheffler B; Laterra J; Li Y
Oncogene; 2015 Jul; 34(30):3994-4004. PubMed ID: 25328136
[TBL] [Abstract][Full Text] [Related]
9. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
[TBL] [Abstract][Full Text] [Related]
10. Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.
Trépant AL; Bouchart C; Rorive S; Sauvage S; Decaestecker C; Demetter P; Salmon I
Tumour Biol; 2015 Mar; 36(3):1943-53. PubMed ID: 25384509
[TBL] [Abstract][Full Text] [Related]
11. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
[TBL] [Abstract][Full Text] [Related]
12. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
[TBL] [Abstract][Full Text] [Related]
14. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
[TBL] [Abstract][Full Text] [Related]
15. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB
Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938
[TBL] [Abstract][Full Text] [Related]
16. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
[TBL] [Abstract][Full Text] [Related]
17. The role of FOSL1 in stem-like cell reprogramming processes.
Pecce V; Verrienti A; Fiscon G; Sponziello M; Conte F; Abballe L; Durante C; Farina L; Filetti S; Paci P
Sci Rep; 2021 Jul; 11(1):14677. PubMed ID: 34282187
[TBL] [Abstract][Full Text] [Related]
18. A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a Transcriptional Program of Neural Stem Cell Identity.
Riddick G; Kotliarova S; Rodriguez V; Kim HS; Linkous A; Storaska AJ; Ahn S; Walling J; Belova G; Fine HA
Sci Rep; 2017 Mar; 7():43605. PubMed ID: 28256619
[TBL] [Abstract][Full Text] [Related]
19. Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.
Guichet PO; Bieche I; Teigell M; Serguera C; Rothhut B; Rigau V; Scamps F; Ripoll C; Vacher S; Taviaux S; Chevassus H; Duffau H; Mallet J; Susini A; Joubert D; Bauchet L; Hugnot JP
Glia; 2013 Feb; 61(2):225-39. PubMed ID: 23047160
[TBL] [Abstract][Full Text] [Related]
20. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
